Homepage
Author:
Glucotrack, Inc.
Posted Date:
May 26, 2026
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
Glucotrack, Inc.
May 26, 2026
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
Glucotrack, Inc.
May 7, 2026
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
Glucotrack, Inc.
April 30, 2026
Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
Glucotrack, Inc.
April 21, 2026
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
Glucotrack, Inc.
March 27, 2026
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
Glucotrack, Inc.
March 10, 2026
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
Glucotrack, Inc.
January 29, 2026
